On Sept. 4, 2015, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices…
On Jun. 8, 2015, the American Medical Association adopted a new policyﾠthat recommended that states have in place…
On Apr. 29, 2015, the U.S. Food and Drug Administration (FDA) announced it had approved Kybella, an injection…
On Mar. 24, 2015, the U.S. Food and Drug Administration (FDA) licensed an additional combined diphtheria and tetanus toxoids…
On Mar. 6, 2015, the The U.S. Food and Drug Administration (FDA) approved filgrastim-sndz (Zarxio, Sandoz, Inc.), the…
On Jan. 23, 2015, Novartis announced the US Food and Drug Administration (FDA) had granted accelerated approval of…
On Dec. 23, 2014, the U.S. Food and Drug Administration (FDA) approved a formulation of Novo Nordisk’s diabetes drug, liraglutide,…
On Dec. 22, 2014, BioCryst Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) had approved RAPIVAB (peramivir…
On Dec. 11, 2014, Merck announced that the FDA had approved GARDASILﾮ9 (Human Papillomavirus 9-valent Vaccine, Recombinant), Merckﾒs…
On Dec. 12, 2014, Sanofi Pasteur announced the U.S. Food and Drug Administration (FDA) had approved the supplemental…
On Oct. 29, 2014, Pfizer announced the FDA has granted accelerated approval of TRUMENBAﾮ (meningococcal group B vaccine)…
On Oct. 15, 2014, Genentech drug Esbriet (pirfenidone) was approved by the U.S. Food and Drug Administration (FDA)…
On Sept. 19, 2014, the Centers for Disease Control and Prevention”s (CDC) Advisory Committee on Immunization Practices (ACIP)…
On Aug. 14. 2014, Genentech announced that the U.S. Food and Drug Administration (FDA) had approved Avastin (bevacizumab)…
On Jun. 2, 2014, Omeros announced that the U.S. Food and Drug Administration (FDA) had approved Omidria™ (phenylephrine…
On Apr. 1, 2014, Sanofi Pasteur announced the U.S. Food and Drug Administration (FDA) had expanded the approved…
On Nov. 13, 2013, Genentech announced that it’s drug Gazyva (obinutuzumab) was approved by the U.S. Food and…
On Aug. 16, 2013, the FDA extended FluLaval IIV (GlaxoSmithKline) age range to include children and teens age…
On Aug. 1, 2013, Novartis announced the U.S. Food and Drug Administration (FDA) had approved Menveo (Meningococcal [Groups…
On Jun. 10, 2013, Sanofi Pasteur announced the U.S. Food and Drug Administration (FDA) had approved the supplemental…
On Feb. 22, 2013, the U.S. Food and Drug Administration (FDA) announced they had licensed ado-trastuzumab emtansine (Kadcyla)…
On Jan. 25, 2013, Pfizer announced the FDA had granted approval for the expansion of the companyﾒs pneumococcal…
On Dec. 14, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved GlaxoSmithKline’s quadrivalent formulation…
On Nov. 20, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved first seasonal influenza…
On Aug. 10. 2012, Genentech announced that Lucentis (ranibizumab injection) was approved by the U.S. Food and Drug…
On Jul. 9, 2012, the FDA created the “Breakthrough Therapy Designation” that expedites development and review of drugs…
On Jun. 24, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved HibMenCY (Menhibrix, GlaxoSmithKline),…
On Jun. 8, 2012, the U.S. Food and Drug Administration (FDA) announced that Genentech’s drug Perjeta (pertuzumab) was…
On May 1, 2012, Pfizer and Protalix BioTherapeutics announced that the U.S. Food and Drug Administration (FDA) had approved…
On Apr. 3, 2012, the Washington State Secretary of Health declared a pertussis epidemic. U.S. Since mid-2011, a…